Avecho, Sandoz ink pact to commercialise CBD for insomnia in Australia Ruchika Sharma6 March 2025 11:30 AM ISTMelbourne: Avecho Biotechnology Limited has announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group...
BioNTech malaria vaccine study placed on clinical hold by USFDA Ruchika Sharma5 March 2025 5:16 PM ISTBioNTech's early-to-mid stage trial of an experimental malaria vaccine has been put on a clinical hold by the U.S. Food and Drug Administration...
USFDA nod to Zydus Lifesciences cancer drug Dasatinib Ruchika Sharma5 March 2025 4:47 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture ...
Aurobindo Pharma arm terminates agreement with Hilleman Labs Singapore for pentavalent vaccine Ruchika Sharma5 March 2025 4:22 PM ISTHyderabad: Aurobindo Pharma has announced that Auro Vaccines Private Limited, a wholly owned step-down subsidiary of the Company, has...
Roche Gazyva application accepted by USFDA for lupus nephritis Ruchika Sharma5 March 2025 1:45 PM ISTGazyva/Gazyvaro is an anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a CRR benefit in lupus nephritis.
JnJ names Darren Snellgrove as Vice President, Investor Relations Ruchika Sharma5 March 2025 12:51 PM ISTNew Brunswick: Johnson & Johnson has announced the appointment of Darren Snellgrove to Vice President of Investor Relations. Jessica Moore,...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Bayer begins Phase II trial with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumors Ruchika Sharma5 March 2025 9:00 AM ISTBerlin: Bayer has announced that the first patient has been enrolled in the global Phase II panSOHO study, an open-label clinical trial,...
Dr Reddy's Labs sells 14 ANDAs to Senores Pharma Ruchika Sharma4 March 2025 5:07 PM ISTThe acquisition will be funded through the Initial Public Offer proceeds raised by Senores Pharmaceuticals Limited.
Gilead Sciences sets aside USD 200 million to resolve HIV drug investigation Ruchika Sharma4 March 2025 4:00 PM ISTNew York: Gilead Sciences has allocated USD 200 million to potentially settle with federal prosecutors to resolve an investigation into its...
GSK Pharma names Carson Dalton as Executive Vice President, Communications and Government Affairs Ruchika Sharma4 March 2025 3:12 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, Communications...
Zydus to make typhoid-shigellosis vaccine for children Ruchika Sharma4 March 2025 2:30 PM ISTAhmedabad: Global lifesciences company, Zydus Lifesciences Limited, has announced the development of a combination vaccine against...
